Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2024 ∙ Mitsikostas, D. D. Caronna, E. De Tommaso, M. Deligianni, C. I. Ekizoglu, E. Bolay, H. Göbel, C. H. Kristoffersen, E. S. Lampl, C. Moro, E. Pozo-Rosich, P. Sellner, J. Terwindt, G. Sieira, P. I.
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Bakare, D. Gobbo, E. Akinsola, K. O. Bakare, A. A. Salako, J. Hanson, C. Herzig van Wees, S. Falade, A. King, C.
Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis
Healthcare workers Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2024 ∙ Hobart, C. Pescarini, J. M. Evans, L. Adil, H. S. Adil, S. T. Deal, A. Carter, J. Matthews, P. C. Hargreaves, S. Clemente, N. S.
Hepatitis B infection and immunity in migrant children and pregnant persons in Europe: a systematic review and meta-analysis
Europe Newborn Children Adolescents Pregnant women Hepatitis B Coverage Ethical issues
Rating:
Not applicable
2024 ∙ Geta, M. Yizengaw, E. Manyazewal, T.
Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis
Africa Children Hepatitis B Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Shah, S. Dahal, K. Thapa, S. Subedi, P. Paudel, B. S. Chand, S. Salem, A. Lammle, M. Sah, R. Krsak, M.
Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis
All age groups Herpes zoster Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Asante, M. A. Michelsen, M. E. Balakumar, M. M. Kumburegama, B. Sharifan, A. Thomsen, A. R. Korang, S. K. Gluud, C. Menon, S.
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
All age groups COVID-19 Efficacy/effectiveness Administration Safety
Rating:
Low
2024 ∙ Alpeza, F. Avermark, H. Gobbo, E. Herzig van Wees, S.
How has co-design been used to address vaccine hesitancy globally? A systematic review
All age groups Human papillomavirus (HPV) COVID-19 Acceptance
Rating:
Not applicable
2024 ∙ Herieka, H. Babalis, D. Tzala, E. Budhathoki, S. Johnson, N. A.
How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities
Europe United Kingdom All age groups COVID-19 Coverage Ethical issues
Rating:
Not applicable
2024 ∙ Li, C. Zhang, M. Karthijekan, K. Fu, X.
How nurses contribute to the elimination of hepatitis B? A systematic review and meta-analysis
Healthcare workers Hepatitis B Acceptance
Rating:
Not applicable
2024 ∙ Isonne, C. Iera, J. Sciurti, A. Renzi, E. De Blasiis, M. R. Marzuillo, C. Villari, P. Baccolini, V.
How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis
All age groups Healthcare workers Acceptance
Rating:
Not applicable
Loading...